Compound composition for inhalation used for treating asthma
US8877740B2 · kind B2 · utility
0Cited by
1References
8Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Feb 1, 2011 |
| Grant date | Nov 4, 2014 |
| Priority date | — |
| Expiry date | Feb 2, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound composition for inhalation comprising β2 receptor agonist and corticosteriod is provided in the present invention. The composition is used as a reliever for a patient with asthma or chronic obstructive pulmonary disease, or a controller in eccentric way, and can reduce drug acute resistance of β2 receptor agonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.